Loading...
XNAS
CTSH
Market cap20bUSD
Jul 09, Last price  
43.40USD
1D
2.29%
1Q
-25.07%
Jan 2017
-22.54%
Name

Cognizant Technology Solutions Corp

Chart & Performance

D1W1MN
XNAS:CTSH chart
P/E
9.22
P/S
0.97
EPS
4.71
Div Yield, %
2.86%
Shrs. gr., 5y
-2.28%
Rev. gr., 5y
4.86%
Revenues
21.11b
+6.95%
1,424,267,0002,135,577,0002,816,304,0003,278,663,0004,592,389,0006,121,156,0007,346,472,0008,843,200,00010,263,000,00012,416,000,00013,487,000,00014,810,000,00016,125,000,00016,783,000,00016,652,000,00018,507,000,00019,428,000,00019,353,000,00019,736,000,00021,108,000,000
Net income
2.23b
-0.45%
232,795,000350,133,000430,845,000534,963,000733,540,000883,618,0001,051,263,0001,228,578,0001,439,267,0001,623,600,0001,553,000,0001,504,000,0002,101,000,0001,842,000,0001,392,000,0002,137,000,0002,290,000,0002,126,000,0002,240,000,0002,230,000,000
CFO
2.88b
+35.73%
252,876,000344,320,000429,705,000672,325,000764,654,000875,152,0001,172,583,0001,423,776,0001,473,010,0002,153,300,0001,621,000,0002,407,000,0002,592,000,0002,499,000,0003,299,000,0002,495,000,0002,568,000,0002,330,000,0002,124,000,0002,883,000,000
Dividend
Nov 18, 20250.31 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Cognizant Technology Solutions Corporation functions as a global professional services firm, delivering a comprehensive suite of consulting, technology, and outsourcing solutions across North America, Europe, and other international markets. Its operations are structured into four primary divisions: Financial Services, Healthcare, Products and Resources, and Communications, Media and Technology. Within the Financial Services sector, Cognizant provides advanced services such as enhancing customer experiences, implementing robotic process automation (RPA), and leveraging analytics and artificial intelligence (AI) to address needs in areas like digital lending, fraud prevention, and modern payment systems. For its Healthcare clients, the company focuses on navigating industry shifts toward consumer-centric models, outcome-based agreements, and digital health initiatives, striving to deliver an integrated, seamless, and patient-focused omnichannel experience. Furthermore, Cognizant assists in optimizing operations across various functions, including clinical development, pharmacovigilance, manufacturing, claims management, enrollment procedures, membership administration, and billing processes. Its clientele in this domain spans healthcare providers, payers, and life sciences organizations, encompassing pharmaceutical, biotechnology, and medical device firms. In the Products and Resources segment, the company develops solutions tailored for manufacturers, retailers, and entities within the travel and hospitality sectors, alongside those engaged in logistics, energy, and utility services. Within the Communications, Media and Technology division, Cognizant supports businesses in creating digital content, crafting personalized user experiences, and expediting digital engineering efforts. This includes serving information, media, entertainment, communications, and technology enterprises. Established in 1994, the company maintains its primary corporate office in Teaneck, New Jersey.
IPO date
Jun 24, 1998
Employees
345,600
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT